Institution
Nanjing Second Hospital
- 16running trials
- 6closed trials
- 1,950publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Recruiting
GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma
Active, not recruiting
A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
Recruiting
Recruiting
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
Not yet recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Active, not recruiting
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)3 recruiting
- Liver cirrhosis3 recruiting
- Hepatitis B2 recruiting
- Liver and biliary tract cancer2 recruiting
- Primary biliary cholangitis2 recruiting
- Tuberculosis2 recruiting
- High blood pressure1 recruiting
Closed trials
Withdrawn
Completed
Completed
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
Completed
A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
Completed
Completed
Registry name variants (3)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The Second Hospital of Nanjing
Nanjing, Jiangsu 210003
16 trials
Nanjing Second Hospital
Nanjing, 210003
5 trials
Second Hospital of Nanjing
Nanjing
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Hepatitis B10 works · 7 trials
- Primary biliary cholangitis5 works · 3 trials
Institution data: ROR 04rhtf097 (CC0-1.0)Updated 15 Nov 2026